国际口腔医学杂志

国际口腔医学杂志 ›› 2024, Vol. 51 ›› Issue (3): 303-309.doi: 10.7518/gjkq.2024012

• 论著 • 上一篇    下一篇

CXCL趋化因子在头颈部鳞状细胞癌中的表达及临床意义

武旭1(),达林泰1,苏尼特2,尚多2,周兴安2,德乐黑巴特尔2()   

  1. 1.呼和浩特市口腔医院口腔颌面外科 呼和浩特 010000
    2.内蒙古医科大学附属医院口腔科 呼和浩特 010050
  • 收稿日期:2023-08-25 修回日期:2023-12-23 出版日期:2024-05-01 发布日期:2024-05-06
  • 通讯作者: 德乐黑巴特尔
  • 作者简介:武旭，主治医师，硕士，Email：1329607312@qq.com
  • 基金资助:
    内蒙古医科大学联合项目(YKD2023LH032);内蒙古自治区高等学校科学研究项目(NJZY21634)

Effect of CXCL chemokines on the diagnosis and prognosis of head and neck quamous cell carcinoma

Xu Wu1(),Lintai Da1,Nite Su2,Duo Shang2,Xing’an Zhou2,Delehei Bateer2()   

  1. 1.Dept. of Oral and Maxillofacial Surgery, Hohhot Stomatological Hospital, Hohhot 010000, China
    2.Dept. of Stomato-logy, Affiliated Hospital of Inner Mongolia Medical University, Hohhot 010050, China
  • Received:2023-08-25 Revised:2023-12-23 Online:2024-05-01 Published:2024-05-06
  • Contact: Delehei Bateer
  • Supported by:
    Joint Project of Inner Mongolia Medical University(YKD2023LH032);Scientific Research Project of Universities in Inner Mongolia Autonomous Region(NJZY21634)

RichHTML

12

PDF (PC)

283

摘要：

目的 探讨CXCL趋化因子家族在头颈部鳞状细胞癌（HNSCC）中的表达及作为其诊断与预后标志物的价值。 方法 利用公共数据库，分析HNSCC中异常表达的CXCL因子类型以及与HNSCC患者不良预后的相关性，计算CXCL家族与免疫因子浸润的相关性。 结果 与正常组织相比，CXCL在HNSCC组织及病理分期中存在差异表达，且与HNSCC患者更长的总生存期（OS）及免疫细胞浸润密切相关；CXCL趋化因子在HNSCC中基因功能主要富集在趋化因子活性等；KEGG通路主要富集细胞因子-细胞因子受体相互作用等；CXCL家族在HNSCC中有一定的突变率。 结论 基于肿瘤生物信息学分析发现，CXCL家族在HNSCC组织中的表达水平与正常组织有差异，且其表达水平与免疫细胞浸润以及肿瘤预后具有相关性，可作为HNSCC预后标志物以及基因治疗靶点。

关键词: 趋化因子, 生物信息学, 头颈部鳞状细胞癌, 预后, 免疫浸润

Abstract:

Objective This study investigated the expression levels of CXCL chemokines in head and neck cancer and their value as diagnostic and prognostic markers. Methods Public databases were used in the analysis of various abnormally expressed CXCL factors in head and neck cancer and their correlation with the poor prognoses of patients with head and neck cancer, and the correlation between CXCL family and immune factor infiltration was determined. Results Compared with normal tissues, CXCL is differentially expressed in head and neck squamous cell carcinoma (HNSCC) tissues and pathological stages, and it is closely related to long overall survival (OS) and immune cell infiltration in patients with HNSCC. CXCL chemokine gene function in HNSCC is mainly concentrated in chemokine activity. The KEGG pathway is mainly concentrated in cytokine-cytokine receptor interaction, and the CXCL family has a certain mutation rate in HNSCC. Conclusion Tumor bioinformatics analysis showed that the expression levels of the CXCL family in HNSCC tissues are different from those in normal tissues and correlated with immune cell infiltration and tumor prognosis, showing potential as prognostic markers for HNSCC and gene therapy targets.

Key words: chemokine, bioinformatics, squamous cell carcinoma of the head and neck, prognosis, immunoinfiltration

中图分类号: 

  • R739.81

图 1

CXCL趋化因子在HNSCC与头颈正常组织中的mRNA表达水平热图"

图 2

HNSCC患者与头颈正常组织中CXCL趋化因子的mRNA表达水平"

图 3

HNSCC组织中与病理分期相关的CXCL趋化因子mRNA表达水平"

图 4

不同CXCL趋化因子在HNSCC患者中的预后价值"

图 5

GO与KEGG富集分析结果"

图 6

HNSCC患者与差异表达CXCL趋化因子基因突变的关系"

1 von Witzleben A, Wang C, Laban S, et al. HNSCC: tumour antigens and their targeting by immunotherapy[J]. Cells, 2020, 9(9): 2103.
2 Johnson DE, Burtness B, Leemans CR, et al. Head and neck squamous cell carcinoma[J]. Nat Rev Dis Primers, 2020, 6(1): 92.
3 Wei LY, Lee JJ, Yeh CY, et al. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1[J]. Oral Oncol, 2019, 88: 115-123.
4 Li YC, Wu TH, Gong SJ, et al. Analysis of the prognosis and therapeutic value of the CXC chemokine family in head and neck squamous cell carcinoma[J]. Front Oncol, 2020, 10: 570736.
5 Li HY, Wu M, Zhao X. Role of chemokine systems in cancer and inflammatory diseases[J]. MedComm, 2022, 3(2): e147.
6 刘宇. 基于生物信息学方法筛选头颈部鳞癌枢纽基因和关联通路[D]. 长春: 吉林大学, 2022.
Liu Y. Screening of head and neck squamous carcinoma hub genes and associated pathways based on bioinformatics methods[D]. Changchun: Jilin University, 2022.
7 Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: an update to the integrated cancer data analysis platform[J]. Neoplasia, 2022, 25: 18-27.
8 Tomczak K, Czerwińska P, Wiznerowicz M. The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge[J]. Contemp Oncol, 2015, 19(1A): A68-A77.
9 Li CW, Tang ZF, Zhang WJ, et al. GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA[J]. Nucleic Acids Res, 2021, 49(W1): W242-W246.
10 Nagy Á, Munkácsy G, Győrffy B. Pancancer survi-val analysis of cancer hallmark genes[J]. Sci Rep, 2021, 11(1): 6047.
11 Li TW, Fu JX, Zeng ZX, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells[J]. Nucleic Acids Res, 2020, 48(W1): W509-W514.
12 GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390(10100): 1211-1259.
13 Chen XY, Chen RP, Jin RF, et al. The role of CXCL chemokine family in the development and progression of gastric cancer[J]. Int J Clin Exp Pathol, 2020, 13(3): 484-492.
14 Yamamoto Y, Kuroda K, Sera T, et al. The clinicopathological significance of the CXCR2 ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in gastric cancer[J]. Anticancer Res, 2019, 39(12): 6645-6652.
15 Łukaszewicz-Zając M, Mroczko B, Szmitkowski M. Chemokines and their receptors in esophageal cancer: the systematic review and future perspectives[J]. Tumour Biol, 2015, 36(8): 5707-5714.
16 宋福勤. YAP通过调控CXCL5/CXCR2介导EGFR突变肺腺癌MDSCs迁移致T细胞增殖受抑的研究[D]. 长春: 吉林大学, 2022.
Song FQ. YAP mediates the migration of MDSCs by regulating CXCL5/CXCR2 resulting in the inhibition of T cell proliferation in EGFR mutant lung adenocarcinoma[D]. Changchun: Jilin University, 2022.
17 王伊婷. CXCL9/CXCR3轴对裸鼠人舌鳞癌模型颈淋巴结转移调节作用的研究[D]. 昆明: 昆明医科大学, 2018.
Wang YT. The role and mechanism of CXCL9/CXCR3 axis regulating oral squamous cell carcinoma metastasis in vivo [D]. Kunming: Kunming Medical University, 2018.
18 Yorozu A, Sekiguchi S, Takasawa A, et al. CXCL12 is expressed by skeletal muscle cells in tongue oral squamous cell carcinoma[J]. Cancer Med, 2023, 12(5): 5953-5963.
19 Wang X, Zhang J, Zhou G. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma[J]. J Oral Pathol Med, 2021, 50(4): 362-370.
20 杨惠雲. TNF相关凋亡诱导配体表达促进食管鳞癌进展的研究[D]. 郑州: 郑州大学, 2020.
Yang HY. Expression of TRAIL in esophageal squamous cell carcinoma promotes tumor progression[D]. Zhengzhou: Zhengzhou University, 2020.
21 Parikh A, Shin J, Faquin W, et al. Malignant cell-specific CXCL14 promotes tumor lymphocyte infiltration in oral cavity squamous cell carcinoma[J]. J Immunother Cancer, 2020, 8(2): e001048.
22 王文涛. CXCL8-CXCR1/2在乳腺癌新辅助化疗中的变化及意义[D]. 青岛: 青岛大学, 2022.
Wang WT. Value and clinical significance of CXCL8-CXCR1/2 axis in neoadjuvant chemotherapy for breast cancer[D]. Qingdao: Qingdao University, 2022.
23 毛天琴. CXCL5预测食管癌新辅助免疫治疗疗效及其与肿瘤免疫的相关性研究[D]. 成都: 电子科技大学, 2022.
Mao TQ. CXCL5 predict the efficacy of neoadjuvant immunotherapy for esophageal cancer and its correlation with tumor microenvironment[D]. Cheng-du: University of Electronic Science and Technology of China, 2022.
24 Liu YE, Wang D, Li ZJ, et al. Pan-cancer analysis on the role of PIK3R1 and PIK3R2 in human tumors[J]. Sci Rep, 2022, 12(1): 5924.
[1] 李冰芷, 刘云坤, 王文轩, 侯泽宇, 唐金茹, 李龙江. 口腔鳞状细胞癌嗜神经侵袭的研究进展[J]. 国际口腔医学杂志, 2024, 51(3): 362-367.
[2] 成应琪,黄正蔚. 上颌窦解剖结构及其与上颌后牙显微根尖手术的关系[J]. 国际口腔医学杂志, 2024, 51(2): 151-156.
[3] 刘世一, 陈中, 张素欣. 程序性死亡受体/配体免疫治疗策略在人乳头瘤病毒阳性头颈部鳞状细胞癌中的研究进展[J]. 国际口腔医学杂志, 2024, 51(1): 21-27.
[4] 李奕君, 徐子昂, 李一. 前哨淋巴结在头颈部鳞状细胞癌检测的应用进展[J]. 国际口腔医学杂志, 2023, 50(5): 521-527.
[5] 李洪芳,陈中,张素欣. 免疫检查点抑制剂联合放射治疗在头颈部鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2022, 49(5): 614-620.
[6] 白皓亮,杨禾,赵蕾. 牙周病风险评估及预后判断工具的研究进展[J]. 国际口腔医学杂志, 2021, 48(6): 696-702.
[7] 马平川,李春洁,李龙江. 唾液腺导管癌的诊疗研究进展[J]. 国际口腔医学杂志, 2021, 48(4): 459-467.
[8] 甘建国,高攀,王晓毅. 循环肿瘤细胞与口腔鳞状细胞癌相关性的研究进展[J]. 国际口腔医学杂志, 2021, 48(2): 205-212.
[9] 郝福,宁毅,孙睿,郑晓旭. 口腔鳞状细胞癌中转化因子2β的表达及潜在的临床意义[J]. 国际口腔医学杂志, 2020, 47(2): 159-165.
[10] 薛伶俐,李雅冬. 经首次根治性手术治疗口腔鳞状细胞癌患者的生存相关影响因素分析[J]. 国际口腔医学杂志, 2020, 47(2): 166-174.
[11] 郝福,孙睿. 头颈部鳞状细胞癌第二原发癌的研究进展[J]. 国际口腔医学杂志, 2019, 46(5): 585-592.
[12] 毛璐,鞠侯雨,任国欣. 程序性细胞死亡受体-1与其配体信号通路的调控及其在头颈鳞状细胞癌治疗中的研究进展[J]. 国际口腔医学杂志, 2018, 45(5): 560-565.
[13] 李锦锦, 潘剑. 自体牙移植及其结合正畸治疗的研究进展[J]. 国际口腔医学杂志, 2018, 45(1): 91-96.
[14] 杜书芳, 唐华. 糖尿病患者种植义齿临床预后评估体系的建立及相关护理[J]. 国际口腔医学杂志, 2017, 44(5): 555-558.
[15] 李儒煌，王霄. 根尖手术预后影响因素的研究进展[J]. 国际口腔医学杂志, 2016, 43(6): 721-724.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] 王昆润. 二甲亚砜和双氯芬酸并用治疗根尖周炎[J]. 国际口腔医学杂志, 1999, 26(06): .
[2] 高卫民,李幸红. 发达国家牙医学院口腔种植学教学现状[J]. 国际口腔医学杂志, 1999, 26(06): .
[3] 张新春. 桩冠修复与无髓牙的保护[J]. 国际口腔医学杂志, 1999, 26(06): .
[4] 彭国光. 颈淋巴清扫术中颈交感神经干的解剖变异[J]. 国际口腔医学杂志, 1999, 26(05): .
[5] 温秀杰. 氟化物对牙本质脱矿抑制作用的体外实验研究[J]. 国际口腔医学杂志, 1999, 26(05): .
[6] 杨锦波. 嵌合体防龋疫苗的研究进展[J]. 国际口腔医学杂志, 1999, 26(05): .
[7] 丁刚. 应用硬组织代用品种植体行丰颏术[J]. 国际口腔医学杂志, 1999, 26(04): .
[8] 蔡霞,李成章. 前列腺素E_2受体EP亚型在牙周炎发病机制中的作用[J]. 国际口腔医学杂志, 2005, 32(06): 461 -462 .
[9] 孟姝,吴亚菲,杨禾. 伴放线放线杆菌产生的细胞致死膨胀毒素及其与牙周病的关系[J]. 国际口腔医学杂志, 2005, 32(06): 458 -460 .
[10] 费晓露,丁一,徐屹. 牙周可疑致病菌对口腔黏膜上皮的粘附和侵入[J]. 国际口腔医学杂志, 2005, 32(06): 452 -454 .